Sarepta Therapeutics, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 2,035 | 0.0% | 94,545 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,583 | 0.0% | 82,141 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,404 | 0.0% | 82,123 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 5,233 | 0.0% | 81,995 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 9,808 | 0.0% | 80,662 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 10,106 | 0.0% | 80,921 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 13,105 | 0.0% | 82,945 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 10,994 | 0.0% | 84,921 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 8,246 | 0.0% | 85,512 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 10,901 | 0.0% | 89,931 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 10,974 | 0.0% | 95,828 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 14,536 | 0.0% | 105,465 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 13,852 | 0.0% | 106,896 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 12,100 | 0.0% | 109,465 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 8,006 | 0.0% | 106,805 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 8,314 | 0.0% | 106,424 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 9,890 | 0.0% | 109,832 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 11,891 | 0.0% | 128,580 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 10,324 | 0.0% | 132,801 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 10,575 | 0.0% | 141,889 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 24,045 | 0.0% | 141,034 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 19,197 | 0.0% | 136,702 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 22,276 | 0.0% | 138,931 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 12,186 | 0.0% | 124,574 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 16,482 | 0.0% | 127,730 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 1,641 | 0.0% | 68,282 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 1,387 | 0.0% | 68,082 | 12/31/2013 |